Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years.
Bruce Anthony Campbell CreeDouglas Lorne ArnoldRobert J FoxRalf GoldPatrick VermerschRalph Hb BenedictAmit Bar-OrDaniela Piani-MeierNicolas RouyrreShannon RitterAjay KilaruGoeril KarlssonGavin GiovannoniLudwig KapposPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
NCT01665144.